310 related articles for article (PubMed ID: 33012018)
21. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
Niknafs YS; Han S; Ma T; Speers C; Zhang C; Wilder-Romans K; Iyer MK; Pitchiaya S; Malik R; Hosono Y; Prensner JR; Poliakov A; Singhal U; Xiao L; Kregel S; Siebenaler RF; Zhao SG; Uhl M; Gawronski A; Hayes DF; Pierce LJ; Cao X; Collins C; Backofen R; Sahinalp CS; Rae JM; Chinnaiyan AM; Feng FY
Nat Commun; 2016 Sep; 7():12791. PubMed ID: 27666543
[TBL] [Abstract][Full Text] [Related]
22. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
23. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
[TBL] [Abstract][Full Text] [Related]
24. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
25. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Shen C; Wang Y; Wu Z; Da L; Gao S; Xie L; Qie Y; Wang Y; Zhang Z; Tian D; Hu H
Oncol Rep; 2020 Nov; 44(5):1831-1850. PubMed ID: 33000254
[TBL] [Abstract][Full Text] [Related]
27. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
28. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
Ma Y; Bu D; Long J; Chai W; Dong J
J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
[TBL] [Abstract][Full Text] [Related]
29. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
[TBL] [Abstract][Full Text] [Related]
30. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.
Qiu P; Dou Y; Ma LZ; Tang XX; Liu XL; Chen JW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10835-10841. PubMed ID: 31858552
[TBL] [Abstract][Full Text] [Related]
32. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
33. LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6.
Zhao YF; Li L; Li HJ; Yang FR; Liu ZK; Hu XW; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11139-11147. PubMed ID: 33215431
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
Zarei M; Malekzadeh K; Omidi M; Mousavi P
Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
[TBL] [Abstract][Full Text] [Related]
35. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
36. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
37. Expression and Clinicopathological Significances of lncRNAs: Could ARA and ZEB2NAT be the Potential Breast Cancer-Related Biomarkers?
Hesami S; Sayar M; Sayyar F; Eshaghkhani Y; Pirhoushiaran M; Khadem Erfan MB; Abdollahzadeh R; Azarnezhad A
Arch Med Res; 2020 Nov; 51(8):851-859. PubMed ID: 32921528
[TBL] [Abstract][Full Text] [Related]
38. Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.
Shi Q; He Y; Zhang X; Li J; Cui G; Zhang X; Wang X
Med Sci Monit; 2019 Sep; 25():7042-7051. PubMed ID: 31536481
[TBL] [Abstract][Full Text] [Related]
39. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
[TBL] [Abstract][Full Text] [Related]
40. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]